<VariationArchive VariationID="134095" VariationName="NM_000400.4(ERCC2):c.1703_1704del (p.Phe568fs)" VariationType="Deletion" Accession="VCV000134095" Version="39" RecordType="classified" NumberOfSubmissions="14" NumberOfSubmitters="14" DateLastUpdated="2024-07-29" DateCreated="2014-06-09" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="137834" VariationID="134095">
      <GeneList>
        <Gene Symbol="ERCC2" FullName="ERCC excision repair 2, TFIIH core complex helicase subunit" GeneID="2068" HGNC_ID="HGNC:3434" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="45349837" stop="45370573" display_start="45349837" display_stop="45370573" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="45854648" stop="45873844" display_start="45854648" display_stop="45873844" Strand="-" />
          </Location>
          <OMIM>126340</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000400.4(ERCC2):c.1703_1704del (p.Phe568fs)</Name>
      <CanonicalSPDI>NC_000019.10:45353295:AAA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="45353296" stop="45353297" display_start="45353296" display_stop="45353297" variantLength="2" positionVCF="45353295" referenceAlleleVCF="TAA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="45856554" stop="45856555" display_start="45856554" display_stop="45856555" variantLength="2" positionVCF="45856553" referenceAlleleVCF="TAA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>F568fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.45353297_45353298del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.45353297_45353298del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.45856555_45856556del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.45856555_45856556del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007067.2" sequenceAccession="NG_007067" sequenceVersion="2" change="g.22291_22292del">
            <Expression>NG_007067.2:g.22291_22292del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000400.4" sequenceAccession="NM_000400" sequenceVersion="4" change="c.1703_1704del" MANESelect="true">
            <Expression>NM_000400.4:c.1703_1704del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000391.1" sequenceAccession="NP_000391" sequenceVersion="1" change="p.Phe568fs">
            <Expression>NP_000391.1:p.Phe568fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_461" sequenceAccession="LRG_461">
            <Expression>LRG_461:g.22291_22292del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_461t1" sequenceAccession="LRG_461t1">
            <Expression>LRG_461t1:c.1703_1704del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000400.3" sequenceAccession="NM_000400" sequenceVersion="3" change="c.1703_1704delTT">
            <Expression>NM_000400.3:c.1703_1704delTT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA158754" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="126340.0011" DB="OMIM" />
        <XRef Type="rs" ID="587778271" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000400.4(ERCC2):c.1703_1704del (p.Phe568fs) AND not specified" Accession="RCV000120767" Version="1">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description DateLastEvaluated="2013-09-19" SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000400.4(ERCC2):c.1703_1704del (p.Phe568fs) AND Xeroderma pigmentosum, group D" Accession="RCV000778548" Version="7">
        <ClassifiedConditionList TraitSetID="5504">
          <ClassifiedCondition DB="MedGen" ID="C0268138">Xeroderma pigmentosum, group D</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-10-25" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000400.4(ERCC2):c.1703_1704del (p.Phe568fs) AND not provided" Accession="RCV001008079" Version="29">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-31" SubmissionCount="5">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000400.4(ERCC2):c.1703_1704del (p.Phe568fs) AND multiple conditions" Accession="RCV002498561" Version="1">
        <ClassifiedConditionList TraitSetID="11632">
          <ClassifiedCondition DB="MedGen" ID="C1853102">Cerebrooculofacioskeletal syndrome 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1866504">Trichothiodystrophy 1, photosensitive</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268138">Xeroderma pigmentosum, group D</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000400.4(ERCC2):c.1703_1704del (p.Phe568fs) AND Leukodystrophy" Accession="RCV003444202" Version="1">
        <ClassifiedConditionList TraitSetID="11396">
          <ClassifiedCondition DB="MedGen" ID="C0023520">Leukodystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-01-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000400.4(ERCC2):c.1703_1704del (p.Phe568fs) AND Cerebrooculofacioskeletal syndrome 2" Accession="RCV003467077" Version="2">
        <ClassifiedConditionList TraitSetID="5505">
          <ClassifiedCondition DB="MedGen" ID="C1853102">Cerebrooculofacioskeletal syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000400.4(ERCC2):c.1703_1704del (p.Phe568fs) AND Xeroderma pigmentosum" Accession="RCV003230409" Version="1">
        <ClassifiedConditionList TraitSetID="7951">
          <ClassifiedCondition DB="MedGen" ID="C0043346">Xeroderma pigmentosum</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-12" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000400.4(ERCC2):c.1703_1704del (p.Phe568fs) AND Inborn genetic diseases" Accession="RCV003343649" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000400.4(ERCC2):c.1703_1704del (p.Phe568fs) AND ERCC2-related disorder" Accession="RCV004529999" Version="1">
        <ClassifiedConditionList TraitSetID="33624">
          <ClassifiedCondition DB="MedGen" ID="CN239291">ERCC2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-24" NumberOfSubmissions="14" NumberOfSubmitters="14" DateCreated="2014-06-09" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11335038</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11709541</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19085937</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19934020</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20633800</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27504877</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9238033</ID>
        </Citation>
        <DescriptionHistory Dated="2023-07-15">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2023-07-03">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-07-17">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-07-17">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-03-14">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-05-26">
          <Description>not provided</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-05-26">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="5504" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4030" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">XP4 XERODERMA PIGMENTOSUM VIII</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0012" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XERODERMA PIGMENTOSUM IV</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XP, GROUP D</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XP, GROUP H</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum, group D</ElementValue>
                <XRef ID="68637004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XP8</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">XPD</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XPDC</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XPH</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16452" />
                <XRef ID="16452" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <XRef ID="C0268138" DB="MedGen" />
              <XRef ID="MONDO:0010212" DB="MONDO" />
              <XRef Type="MIM" ID="278730" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5505" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="765" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cerebrooculofacioskeletal syndrome 2</ElementValue>
                <XRef ID="Cerebrooculofacioskeletal+syndrome+2/7946" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012553" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">COFS2</ElementValue>
                <XRef Type="MIM" ID="610756" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15497" />
                <XRef ID="15497" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C1853102" DB="MedGen" />
              <XRef ID="MONDO:0012553" DB="MONDO" />
              <XRef Type="MIM" ID="610756" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="11632" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4296" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">TAY SYNDROME</ElementValue>
                <XRef Type="MIM" ID="601675" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TRICHOTHIODYSTROPHY WITH CONGENITAL ICHTHYOSIS</ElementValue>
                <XRef Type="MIM" ID="601675" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PIBIDS syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Trichothiodystrophy 1, photosensitive</ElementValue>
                <XRef ID="MONDO:0011125" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TTD1</ElementValue>
                <XRef Type="MIM" ID="601675" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">TTDP</ElementValue>
                <XRef Type="MIM" ID="601675" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5270" />
                <XRef ID="5270" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="33364" DB="Orphanet" />
              <XRef ID="670" DB="Orphanet" />
              <XRef ID="C1866504" DB="MedGen" />
              <XRef ID="MONDO:0011125" DB="MONDO" />
              <XRef Type="MIM" ID="601675" DB="OMIM" />
            </Trait>
            <Trait ID="765" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cerebrooculofacioskeletal syndrome 2</ElementValue>
                <XRef ID="Cerebrooculofacioskeletal+syndrome+2/7946" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012553" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">COFS2</ElementValue>
                <XRef Type="MIM" ID="610756" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15497" />
                <XRef ID="15497" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C1853102" DB="MedGen" />
              <XRef ID="MONDO:0012553" DB="MONDO" />
              <XRef Type="MIM" ID="610756" DB="OMIM" />
            </Trait>
            <Trait ID="4030" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">XP4 XERODERMA PIGMENTOSUM VIII</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="126340.0012" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XERODERMA PIGMENTOSUM IV</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XP, GROUP D</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XP, GROUP H</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum, group D</ElementValue>
                <XRef ID="68637004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XP8</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">XPD</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XPDC</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XPH</ElementValue>
                <XRef Type="MIM" ID="278730" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16452" />
                <XRef ID="16452" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <XRef ID="C0268138" DB="MedGen" />
              <XRef ID="MONDO:0010212" DB="MONDO" />
              <XRef Type="MIM" ID="278730" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="11396" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14617" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Metachromatic leukodystrophy variant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Leukodystrophy</ElementValue>
                <XRef ID="319799" DB="GeneTests" />
                <XRef ID="Leukodystrophy/4198" DB="Genetic Alliance" />
                <XRef ID="HP:0002415" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0019046" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypomyelinating leukodystrophy</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6895" />
                <XRef ID="6895" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="AAP, 2021">
                <URL>https://publications.aap.org/pediatrics/article/148/3/e2021053126/181065/Leukodystrophies-in-Children-Diagnosis-Care-and</URL>
                <CitationText>Leukodystrophies in Children: Diagnosis, Care, and Treatment, Pediatrics (2021) 148 (3): e2021053126.</CitationText>
              </Citation>
              <XRef ID="68356" DB="Orphanet" />
              <XRef ID="C0023520" DB="MedGen" />
              <XRef ID="MONDO:0019046" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS312080" DB="OMIM" />
              <XRef Type="primary" ID="HP:0002415" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006926" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007079" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7951" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="7021" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum</ElementValue>
                <XRef ID="Xeroderma+pigmentosum/7564" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019600" DB="MONDO" />
                <XRef ID="44600005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosa</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7910" />
                <XRef ID="7910" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="910" DB="Orphanet" />
              <XRef ID="C0043346" DB="MedGen" />
              <XRef ID="MONDO:0019600" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="33624" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36488" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ERCC2-related conditions</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ERCC2-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">ERCC2-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ERCC2-Related Disorders</ElementValue>
              </Name>
              <XRef ID="CN239291" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="281900" SubmissionDate="2014-05-29" DateLastUpdated="2014-06-09" DateCreated="2014-06-09">
        <ClinVarSubmissionID localKey="MedGen:CN169374" />
        <ClinVarAccession Accession="SCV000084931" DateUpdated="2014-06-09" DateCreated="2014-06-09" Type="SCV" Version="1" SubmitterName="ITMI" OrgID="504914" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-09-19">
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Whole_cohort</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>681</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>Complete Genomics</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>reference population</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0.0007</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>African</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>43</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>Complete Genomics</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>reference population</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>African_European</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>46</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>Complete Genomics</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>reference population</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Central_Asian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>50</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>Complete Genomics</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>reference population</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>East_Asian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>62</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>Complete Genomics</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>reference population</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>European</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>331</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>Complete Genomics</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>reference population</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0.0015</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Hispanic</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>118</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>Complete Genomics</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>reference population</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="-" referenceAllele="AA" start="45856554" stop="45856555" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">AllHighlyPenetrant</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="CN169374" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">24728327</ID>
        </Citation>
        <Comment Type="public">Please see associated publication for description of ethnicities</Comment>
        <SubmissionNameList>
          <SubmissionName>Cancer_genes_01</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="38559" SubmissionDate="2016-08-09" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="126340.0011_XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D" title="ERCC2, 2-BP DEL, 1781TT_XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D" />
        <ClinVarAccession Accession="SCV000038559" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-10-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Broughton et al. (2001) described a 3-year-old girl with sun sensitivity and mental and physical developmental delay (XPD; 278730) who was compound heterozygous for mutations in the ERCC2 gene: a deletion of dinucleotide TT at 1781-1782, resulting in a frameshift and an immediate stop codon, and a complex alteration with deletion of trinucleotide AGA at 1823-1825 and insertion of TTTCGG at this site (126340.0012). The latter resulted in an in-frame alteration of codons 582 and 583 plus the addition of a glutamate residue after codon 583 adjacent to the helicase domain V.</Attribute>
              <Citation>
                <ID Source="PubMed">11709541</ID>
              </Citation>
              <XRef DB="OMIM" ID="278730" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <Name>ERCC2, 2-BP DEL, 1781TT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 1781TT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="126340.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1455478" SubmissionDate="2017-12-08" DateLastUpdated="2018-05-12" DateCreated="2018-05-12">
        <ClinVarSubmissionID localKey="CMGVARID00906|HPO:HP:0006926" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000747386" DateUpdated="2018-05-12" DateCreated="2018-05-12" Type="SCV" Version="1" SubmitterName="Centre for Mendelian Genomics, University Medical Centre Ljubljana" OrgID="505952" OrganizationCategory="clinic" OrgAbbreviation="CMG-UMCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000400.3:c.1703_1704delTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0006926" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>CMG_Slovenia_Submission_2</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1789914" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="792571" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000914846" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11709541</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27504877</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20633800</ID>
          </Citation>
          <Comment>The ERCC2 c.1703_1704delTT (p.Phe568TyrfsTer2) variant results in a frameshift and is predicted to result in premature termination of the protein. The p.Phe568TyrfsTer2 variant has been reported in at least two studies, in which it is found in a compound heterozygous state in two unrelated individuals with features of both xeroderma pigmentosa (XP) and trichothiodystrophy (TTD) (Broughton et al., 2001; Zhou et al., 2010). Control data are unavailable for this variant, which is reported at a frequency of 0.000174 in the European (non-Finnish) population of the Genome Aggregation Database. Due to the potential impact of frameshift variants and the limited number of cases, this variant is classified as likely pathogenic for xeroderma pigmentosum. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="T" referenceAllele="TAA" start="45856553" stop="45856555" variantLength="3" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000400.3:c.1703_1704delTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="278730" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5458593" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000400.4:c.1703_1704del|OMIM:278730;601675;610756" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002810372" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000400.4:c.1703_1704del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="278730" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="601675" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610756" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2305811" SubmissionDate="2022-11-16" DateLastUpdated="2023-03-04" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDXSV:247597" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001167818" DateUpdated="2023-03-04" DateCreated="2020-03-16" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Identified with a second ERCC2 variant in individuals with features of xeroderma pigmentosum and trichothiodystrophy in the published literature (Broughton et al., 2001; Zhou et al., 2010), and in a patient with trichothiodystrophy referred for genetic testing at GeneDx; Reported previously in the heterozygous state in association with breast and/or ovarian cancer susceptibility (Lhota et al., 2016; Maxwell et al., 2016; Yehia et al., 2018; Rump et al., 2016); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 26822949, 27153395, 27504877, 29684080, 11709541, 24728327, 20633800, 26689913, 31589614, 29625052)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:183667</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000400.3:c.1703_1704del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_142_20221116054205</SubmissionName>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7343590" SubmissionDate="2023-05-17" DateLastUpdated="2023-06-03" DateCreated="2023-06-03">
        <ClinVarSubmissionID localKey="NM_000400.3:c.1703_1704delTT|MedGen:C0043346" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003928965" DateUpdated="2023-06-03" DateCreated="2023-06-03" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11709541</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20633800</ID>
          </Citation>
          <Comment>Variant summary: ERCC2 c.1703_1704delTT (p.Phe568TyrfsX2) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic within ClinVar (e.g. c.1984C&gt;T [p.Gln662Ter], c.2005del [p.Arg669fs]). The variant allele was found at a frequency of 0.0001 in 282568 control chromosomes (gnomAD), predominantly at a frequency of 0.00019 within the Non-Finnish European subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in ERCC2 causing Xeroderma Pigmentosum (0.0001 vs 0.00061), allowing no conclusion about variant significance. c.1703_1704delTT has been reported in the literature in compound heterozygous individuals affected with Xeroderma Pigmentosum (Broughton_2001) and Trichothiodystrophy (Zhou_2010). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Eight ClinVar submitters have assessed the variant since 2014: two classified the variant as likely pathogenic, and six as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000400.3:c.1703_1704delTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0043346" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13370974</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3924650" SubmissionDate="2023-07-12" DateLastUpdated="2023-07-16" DateCreated="2021-11-06">
        <ClinVarSubmissionID localKey="Chr.19_45353295_45353297_TAA_T|not provided" />
        <ClinVarAccession Accession="SCV002009198" DateUpdated="2023-07-16" DateCreated="2021-11-06" Type="SCV" Version="3" SubmitterName="Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden" OrgID="505632" OrganizationCategory="clinic" OrgAbbreviation="KGE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="19" alternateAllele="T" referenceAllele="TAA" start="45353295" stop="45353297" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10612882</SubmissionName>
          <SubmissionName>SUB13603663</SubmissionName>
          <SubmissionName>SUB13676335</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7693490" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="16270489|ERCC2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004113981" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The ERCC2 c.1703_1704delTT variant is predicted to result in a frameshift and premature protein termination (p.Phe568Tyrfs*2). This variant has been reported in the compound heterozygous state in two individuals with xeroderma pigmentosum (Broughton et al 2001. PubMed ID: 11709541, reported as 1781-1782 del TT; Zhou et al. 2010. PubMed ID: 20633800). This variant has also been reported in the heterozygous state in individuals with cancer, but it was also reported in controls (see for example, Lhota F et al 2016. PubMed ID: 26822949; Maxwell KN et al 2016. PubMed ID: 27153395). This variant is reported in 0.019% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/19-45856553-TAA-T). Functional studies in vitro indicated that this variant disrupts excision repair (Rump A et al 2016. PubMed ID: 27504877), and frameshift variants in ERCC2 are expected to be pathogenic. Taken together, this variant is of uncertain clinical significance for predisposition to cancer; it is interpreted as pathogenic for autosomal recessive xeroderma pigmentosum.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000400.3:c.1703_1704delTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ERCC2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3965798" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="884659117138d1d91289bc31ef04ab49d3987b47c2a29f7d5879f5b01342e55a|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002022197" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000400.3:c.1703_1704del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7845272" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000400.4:c.1703_1704del|OMIM:610756" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004194615" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000400.4:c.1703_1704del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610756" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3850142" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2021-10-08">
        <ClinVarSubmissionID localKey="110077|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001961833" DateUpdated="2024-07-15" DateCreated="2021-10-08" Type="SCV" Version="17" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>ERCC2: PVS1, PS3:Supporting</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="T" referenceAllele="TAA" start="45856553" stop="45856555" variantLength="3" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4197947" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="3791887|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002185865" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9238033</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11335038</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19085937</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19934020</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11709541</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Phe568Tyrfs*2) in the ERCC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC2 are known to be pathogenic (PMID: 9238033, 11335038, 19085937, 19934020). This variant is present in population databases (rs587778271, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with clinical features of xeroderma pigmentosum with trichothiodystrophy (PMID: 11709541). ClinVar contains an entry for this variant (Variation ID: 134095). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.45856554_45856555del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7586314" SubmissionDate="2024-04-19" DateLastUpdated="2024-05-01" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="a469828|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004059603" DateUpdated="2024-05-01" DateCreated="2023-10-28" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20633800</ID>
          </Citation>
          <Comment>The c.1703_1704delTT (p.F568Yfs*2) alteration, located in exon 18 (coding exon 18) of the ERCC2 gene, consists of a deletion of 2 nucleotides from position 1703 to 1704, causing a translational frameshift with a predicted alternate stop codon after 2 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, this alteration has an overall frequency of 0.01% (29/282568) total alleles studied. The highest observed frequency was 0.019% (25/128994) of European (non-Finnish) alleles. This variant has been reported in combination with a second ERCC2 variant of unknown significance in an individual with clinical features consistent with ERCC2-related spectrum disorders (Zhou, 2010). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000400.3:c.1703_1704delTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough091523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5458593" TraitType="Disease" MappingType="XRef" MappingValue="278730" MappingRef="OMIM">
        <MedGen CUI="C0268138" Name="Xeroderma pigmentosum, group D" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7586314" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7693490" TraitType="Disease" MappingType="Name" MappingValue="ERCC2-related condition" MappingRef="Preferred">
        <MedGen CUI="CN239291" Name="ERCC2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3965798" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5458593" TraitType="Disease" MappingType="XRef" MappingValue="601675" MappingRef="OMIM">
        <MedGen CUI="C1866504" Name="Trichothiodystrophy 1, photosensitive" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7845272" TraitType="Disease" MappingType="XRef" MappingValue="610756" MappingRef="OMIM">
        <MedGen CUI="C1853102" Name="Cerebrooculofacioskeletal syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="38559" TraitType="Disease" MappingType="Name" MappingValue="XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D" MappingRef="Preferred">
        <MedGen CUI="C0268138" Name="Xeroderma pigmentosum, group D" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3850142" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="281900" TraitType="Disease" MappingType="Name" MappingValue="AllHighlyPenetrant" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3924650" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1455478" TraitType="Finding" MappingType="XRef" MappingValue="HP:0006926" MappingRef="HP">
        <MedGen CUI="C0023520" Name="Leukodystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2305811" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5458593" TraitType="Disease" MappingType="XRef" MappingValue="610756" MappingRef="OMIM">
        <MedGen CUI="C1853102" Name="Cerebrooculofacioskeletal syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1789914" TraitType="Disease" MappingType="XRef" MappingValue="278730" MappingRef="OMIM">
        <MedGen CUI="C0268138" Name="Xeroderma pigmentosum, group D" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7343590" TraitType="Disease" MappingType="XRef" MappingValue="C0043346" MappingRef="MedGen">
        <MedGen CUI="C0043346" Name="Xeroderma pigmentosum" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4197947" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

